Russell Investments Group
ORGS

Russell Investments Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Russell Investments Group’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,730
Closed -$187K – 3224
2020
Q3 		$187K Buy
+3,730
New +$202K ﹤0.01% 2793

Other funds holding ORGS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Investments Group's ORGS Position: Q4 2020 in Review

Russell Investments Group sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2020, closing a stake of 3,730 shares — an estimated $187K sold.

Russell Investments Group first reported a position in ORGS in Q3 2020 and held it in 1 quarter. The position peaked at $187K in Q3 2020. 37 funds tracked by Wall St. Rank hold ORGS as of Q4 2020.

  • Russell Investments Group reported no remaining Orgenesis Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Russell Investments Group sold 3,730 Orgenesis Inc. Common Stock shares in Q4 2020, an estimated $187K.
  • Russell Investments Group first reported a position in Orgenesis Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Russell Investments Group's Orgenesis Inc. Common Stock position peaked at $187K in Q3 2020.
  • 37 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.